To determine if BRAFV600E activates the Hippo tumor-suppressor pathway in vitro, we induced BRAFV600E expression and examined the relative levels of active, phosphorylated LATS1/2 at the hydrophobic motif (T1079)27. This evidence concerns the gene LATS1 and neoplasm.